Cargando…

Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin–DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model

Aurora A kinase (Aurora A) is a serine/threonine kinase regulating control of multiple events during cell-cycle progression. Playing roles in promoting proliferation and inhibiting cell death in cancer cells leads Aurora A to become a target for cancer therapy. It is overexpressed and associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winardi, Daniel, Chu, Pei-Yi, Chen, Guan-Yu, Wang, Ke, Hsu, Wei-Yu, Hsieh, Ching-Liang, Chen, Yung-Hsiang, Wu, Yang-Chang, Yang, Juan-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836832/ https://www.ncbi.nlm.nih.gov/pubmed/35163790 http://dx.doi.org/10.3390/ijms23031868

Ejemplares similares

Transcriptome profile of OVCAR3 cisplatin-resistant ovarian cancer cell line
por: Sakhare, Shruti S, et al.
Publicado: (2014)

Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation
por: Yang, Ruhui, et al.
Publicado: (2022)

Detection and Characterization of Single Cisplatin Adducts on DNA by Nanopore Sequencing
por: Zhao, Xinjia, et al.
Publicado: (2021)

Cisplatin adducts of DNA as precursors for nanostructured catalyst materials
por: Englert, Klaudia, et al.
Publicado: (2020)

Effects of SC-560 in Combination with Cisplatin or Taxol on Angiogenesis in Human Ovarian Cancer Xenografts
por: Li, Wei, et al.
Publicado: (2014)

Chloroquine-Enhanced Efficacy of Cisplatin in the Treatment of Hypopharyngeal Carcinoma in Xenograft Mice
por: Zhao, Xing-guo, et al.
Publicado: (2015)

HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
por: He, Yafeng, et al.
Publicado: (2015)

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor
por: Hoebers, F. J. P., et al.
Publicado: (2007)

Antitumor Effects of Turmeric on OVCAR-3 Ovarian Cancer Cell Lines
por: Gurer, Hulusi Goktug, et al.
Publicado: (2022)

Cisplatin‐resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib
por: Wang, Lihong, et al.
Publicado: (2017)

Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives
por: Liu, Yazhou, et al.
Publicado: (2017)

Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts
por: Wang, Yang, et al.
Publicado: (2018)

Boosting cisplatin chemotherapy by nanomotor-enhanced tumor penetration and DNA adducts formation
por: Xu, Lihua, et al.
Publicado: (2022)

Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models
por: Oliva, P, et al.
Publicado: (2012)

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
por: Sommariva, Michele, et al.
Publicado: (2013)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs
por: Shen, Ching-Ju, et al.
Publicado: (2016)

Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
por: Meijer, C., et al.
Publicado: (1997)

Hydrated electrons induce the formation of interstrand cross-links in DNA modified by cisplatin adducts
por: Behmand, B, et al.
Publicado: (2020)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

Anti-Metastatic Effects of Antrodan with and without Cisplatin on Lewis Lung Carcinomas in a Mouse Xenograft Model
por: Chen, Pei-Chun, et al.
Publicado: (2018)

Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
por: Zhou, Fuxing, et al.
Publicado: (2018)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

P21-Activated Kinase 7 Mediates Cisplatin-Resistance of Esophageal Squamous Carcinoma Cells with Aurora-A Overexpression
por: He, Shun, et al.
Publicado: (2014)

Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway
por: Huang, Wei-Lin, et al.
Publicado: (2016)

Cisplatin induces stemness in ovarian cancer
por: Wiechert, Andrew, et al.
Publicado: (2016)

Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei
por: Liedert, Bernd, et al.
Publicado: (2006)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts
por: Cao, Long-Hui, et al.
Publicado: (2016)

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
por: Washington, M N, et al.
Publicado: (2015)

Fangchinoline Promotes Autophagy and Inhibits Apoptosis in Osteoporotic Rats
por: Zhu, Wenjun, et al.
Publicado: (2019)

MicroRNA-1284 Inhibits Cell Viability and Induces Apoptosis of Ovarian Cancer Cell Line OVCAR3
por: Pan, Changqing, et al.
Publicado: (2016)

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models
por: Syn, Nicholas L., et al.
Publicado: (2018)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

Effect of fangchinoline on root resorption during rat orthodontic tooth movement
por: Bao, Xingfu, et al.
Publicado: (2012)

Anti-metastatic activity of fangchinoline in human gastric cancer AGS cells
por: Chen, Zhengrong, et al.
Publicado: (2017)

Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF
por: Polacchini, Alessio, et al.
Publicado: (2016)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6i9j2evfquh1v6uuj2fm01akgd